BINGO!!! As I was suspecting the share price downdraft was as much to do about word getting out on the apaz NDA rejection by the FDA 3 days earlier as it did with no poziotinib abstract at SABCS!
Spectrum Pharma says U.S. FDA rejects its bladder cancer drug
ReutersNovember 18, 2016 Nov 18 (Reuters) - Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration rejected the drugmaker's bladder cancer treatment. The company said it was considering a new smaller study for the drug, apaziquone, that would replace the ongoing late-stage study in which patient enrollment has been stopped.